Journal Information
Vol. 46. Issue 7.
Pages 394-395 (July 2010)
Vol. 46. Issue 7.
Pages 394-395 (July 2010)
Letters to the Editor
Full text access
Miliary Tuberculosis Due to BCG in an Asymptomatic Patient: Initial Onset or a Condition Not Yet Described?
Tuberculosis miliar por BCG en un paciente asintomático: ¿afectación inicial o una entidad no descrita?
Visits
4502
This item has received
Article information
Full text is only aviable in PDF
References
[1.]
H. Koga, M. Kuroda, S. Kudo, A. Yamaguchi, M. Usami, T. Suzuki, et al.
Adverse drug reactions of intravesical bacillus Calmette-Guérin instillation and risk factors of the developmentof adverse drug reactions in superficial cancer and carcinoma in situ of the bladder.
Int J Urol, 12 (2005), pp. 145-151
[2.]
D.L. Lamm, A.P.M. Van der Meijden, A. Morales, S.A. Brosman, W.J. Catalona, H.W. Herr, et al.
Incidente and treatment of complications of Bacillus Calmette-Guérin intravesical therapy in superficial bladder cancer.
J Urol, 147 (1992), pp. 596-600
[3.]
O.Y. Gonzalez, D.M. Musher, I. Brar, S. Furgeson, M.R. Boktour, E.J. Septimus, et al.
Spectrum of bacille Calmette-Guérin (BCG) infection after intravesical BCG immunotherapy.
Clin Infect Dis, 36 (2003), pp. 140-148
[4.]
M. Elkabani, J.N. Greene, A.L. Vincent, S. VanHook, R.L. Sandin.
Disseminated Mycobacterium bovis after intravesicular bacillus Calmette-Guerin treatments for bladder cancer.
Cancer Control, 7 (2000), pp. 476-481
Copyright © 2010. Sociedad Española de Neumología y Cirugía Torácica